EMA — authorised 22 August 2024
- Application: EMEA/H/C/006139
- Marketing authorisation holder: ALK-Abelló A/S
- Local brand name: Eurneffy
- Indication: Eurneffy is indicated in the emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products and other allergens as well as idiopathic or exercise induced anaphylaxis. Treatment is indicated for adults and children aged 4 years and over with a body weight of 15 kg or more.
- Status: approved
The European Medicines Agency (EMA) granted marketing authorisation for Eurneffy (blood and adrenaline) on 22 August 2024. Eurneffy is indicated for the emergency treatment of anaphylaxis due to insect stings or bites, foods, medicinal products, and other allergens, as well as idiopathic or exercise-induced anaphylaxis. The treatment is approved for adults and children aged 4 years and over with a body weight of 15 kg or more.